Procter & Gamble Health share price
You have to be logged in to add this to Watchlist.- ₹5,841.15(0.66%)December 4, 2025 15:27:37 PM IST
- NSE
- BSE
- Vol : 3.74 K (NSE + BSE)Last 20 day avg : 7.62 K
Procter & Gamble Health is trading 0.66% upper at Rs 5,841.15 as compared to its last closing price. Procter & Gamble Health has been trading in the price range of 5,866.90 & 5,784.20. Procter & Gamble Health has given 11.36% in this year & 0.30% in the last 5 days. Procter & Gamble Health has TTM P/E ratio 34.16 as compared to the sector P/E of 32.52.The company posted a net profit of 88.54 Crores in its last quarter.Listed peers of Procter & Gamble Health include Granules India (0.07%), Marksans Pharma (-1.50%), Procter & Gamble Health (0.66%).The Mutual Fund holding in Procter & Gamble Health was at 10.56% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Procter & Gamble Health was at 7.24% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 04, 2025, 11:31 PM UTC
- BetaLow volatility0.09Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.14Annual dividends as a percentage of the stock price.
- P/BHigher than historical values18.03The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values31.59Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Granules India | Bullish | 568.00 | 0.07 | 13,783.59 | 24.86 | 3.2 | 0.31 | 12.67 |
| Marksans Pharma | Bearish | 187.20 | -1.50 | 8,449.88 | 30.89 | 4.77 | 0.23 | 10.67 |
| Procter & Gamble Health | Neutral | 5,841.15 | 0.66 | 9,704.66 | 44.61 | 18.05 | 2.65 | 1.28 |
| Shilpa Medicare | Bearish | 335.00 | -0.04 | 6,560.80 | 90.06 | 3.67 | - | 9.83 |
| Aarti Pharmalabs | Moderately Bearish | 721.05 | 1.77 | 6,515.89 | 30.09 | 4.12 | - | 6.18 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-05 | Quarterly Results & Interim Dividend |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-04 | Quarterly Results |
| 2024-08-21 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE199A01012
- BSE Code500126
- NSE CodePGHL
Procter & Gamble Health is trading at 5841.15 as on Thu Dec 04 2025 09:57:37. This is 0.66% upper as compared to its previous closing price of 5802.85.
The market capitalization of Procter & Gamble Health is 9704.66 Cr as on Thu Dec 04 2025 09:57:37.
The 52 wk high for Procter & Gamble Health is 6700.00 whereas the 52 wk low is 4916.00
Procter & Gamble Health can be analyzed on the following key metrics -
- TTM P/E: 34.16
- Sector P/E: 32.52
- Dividend Yield: 2.14%
- D/E ratio: 0.01
Procter & Gamble Health reported a net profit of 234.41 Cr in 2025.
The Mutual Fund Shareholding was 10.56% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Procter & Gamble Health QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.